chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Inappropriate schedule of product administration, Pain
Clinical narrative: Diarrhea; Achy; Throwing up all day; Fever; Chills on and off; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the arm left on 29Mar2021 at 09:30 (inappropriate schedule of vaccine administered) (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included interstitial cystitis. The patient never had any allergy to medication, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included unspecified multivitamins (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the arm left on 11Mar2021 at 01:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient reported that, she was fine on the first day till 01:00, eleven hours after the vaccination (as reported- discrepancy). On 30Mar2021 at 01:00, she threw up all day, fever of 100 (unspecified units), and had chills on and off. On 31Mar2021, the patient still felt like she wanted to throw up, she still had chills and felt achy. On 01Apr2021 at 02:00, the patient experienced diarrhea and still felt like she wanted to throw up. The adverse events did not result in a doctor or other healthcare professional office/ clinic visit/ emergency room/ department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events felt like throwing up, fever, chills, achy and diarrhea were not resolved at the time of this report. The clinical outcome of the event inappropriate schedule of vaccine was unknown at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Diarrhea; Achy; Throwing up all day; Fever; Chills on and off; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the arm left on 29Mar2021 at 09:30 (inappropriate schedule of vaccine administered) (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included interstitial cystitis. The patient never had any allergy to medication, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included unspecified multivitamins (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the arm left on 11Mar2021 at 01:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient reported that, she was fine on the first day till 01:00, eleven hours after the vaccination (as reported- discrepancy). On 30Mar2021 at 01:00, she threw up all day, fever of 100 (unspecified units), and had chills on and off. On 31Mar2021, the patient still felt like she wanted to throw up, she still had chills and felt achy. On 01Apr2021 at 02:00, the patient experienced diarrhea and still felt like she wanted to throw up. The adverse events did not result in a doctor or other healthcare professional office/ clinic visit/ emergency room/ department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events felt like throwing up, fever, chills, achy and diarrhea were not resolved at the time of this report. The clinical outcome of the event inappropriate schedule of vaccine was unknown at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 17Feb2021 at 09:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atorvastatin calcium (LIPITOR), sertraline hydrochloride (ZOLOFT), ascorbic acid/vitamin C (MANUFACTURER UNKNOWN) and multi vitamin (CENTRUM). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 27Jan2021 at 09:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Feb2021, the patient underwent a rapid test (nasal swab) for COVID-19 and tested negative. On 30Mar2021 at 21:00, the patient experienced a sore throat and reported that he would get a COVID-19 test done as a precautionary measure. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event sore throat was resolved on an unspecified date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pyrexia, Vomiting
Clinical narrative: Fever; Aches; Exhaustion; Headache; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in the left arm on 29Mar2021 at 00:00 (at the age of 63-years-old), as a single dose for Covid-19 immunisation. Medical history included high blood pressure and COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medication included paroxetine (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), propanol (MANUFACTURER UNKNOWN) and losartan hydrochlorothiazide (MANUFACTURER UNKNOWN); all taken for unknown indication from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 08Mar2021 at 00:00 (at the age of 63-years-old), as a single dose for Covid-19 immunisation. The patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 20:00, the patient experienced fever, aches, exhaustion, headache and vomiting for four days. The patient received acetaminophen (MANUFACTURER UNKNOWN) and antacids (MANUFACTURER UNKNOWN) as a treatment drugs for the fever, aches, exhaustion, headache and vomiting. The clinical outcome of fever, aches, exhaustion, headache and vomiting was not resolved at the time of this report.  No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chest discomfort, Chills, Dizziness, Migraine
Clinical narrative: Chills; body aches; muscle pain; Nausea; migraine; fever of 100.7; light headedness; heavy chest discomfort; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via an unspecified route of administration in the right arm on 30Mar2021 at 14:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis. The patient did not have any known allergy. Concomitant medications included sertraline hydrochloride (ZOLOFT), doxycycline (MANUFACTURER UNKNOWN), calcium carbonate (TUMS), vitamin D (MANUFACTURER UNKNOWN), B12 (MANUFACTURER UNKNOWN) and meloxicam (MELOXIC). Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 15:45 (also reported as between 16:00 to 23:00), the patient experienced chills, body aches, muscle pain, nausea, migraine, fever of 100.7, light headedness and heavy chest discomfort. The patient did not receive any treatment for the events. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, body aches, muscle pain, nausea, migraine, fever of 100.7, light headedness and heavy chest discomfort was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: Chills; body aches; muscle pain; Nausea; migraine; fever of 100.7; light headedness; heavy chest discomfort; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via an unspecified route of administration in the right arm on 30Mar2021 at 14:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis. The patient did not have any known allergy. Concomitant medications included sertraline hydrochloride (ZOLOFT), doxycycline (MANUFACTURER UNKNOWN), calcium carbonate (TUMS), vitamin D (MANUFACTURER UNKNOWN), B12 (MANUFACTURER UNKNOWN) and meloxicam (MELOXIC). Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 15:45 (also reported as between 16:00 to 23:00), the patient experienced chills, body aches, muscle pain, nausea, migraine, fever of 100.7, light headedness and heavy chest discomfort. The patient did not receive any treatment for the events. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, body aches, muscle pain, nausea, migraine, fever of 100.7, light headedness and heavy chest discomfort was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Influenza like illness, Pain, Vaccination site pain
Clinical narrative: Flu like symptoms; feeling awful; . Body aches; fatigue; vaccination site pain; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 30Mar2021 at 14:00(at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, graves' disease and depression. The patient had no known allergy. Concomitant medications included losartan (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), thyroid (MANUFACTURER UNKNOWN) and paroxetine hydrochloride (PAXIL) from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 1400 the patient experienced injection site hurt and on 31Mar2021 at 07:00 the patient experienced flu like symptoms, body ache and fatigue (so that the patient couldn't work) and feeling awful to sit up in bed was painful for the patient. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient included treatment with ADVIL for the adverse events and slept the entire day. The clinical outcome of the events of flu like symptoms, body ache, fatigue, injection site hurt and feeling awful was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Vaccination site pain; Headache; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er8734) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient had no allergies to medications, food or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 31Mar2021 at 18:00, the patient experienced vaccination site pain and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures included treatment with tylenol for the reported events. The clinical outcome of the events vaccination site pain and headache were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Yellow skin
Clinical narrative: left palm turned yellow; This is a spontaneous report from a contactable other healthcare professional, the patient. A 26-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Jan2021 at 09:15 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Concomitant medications included fish oil (MANUFACTURER UNKNOWN), cranberrysup (MANUFACTURER UNKNOWN), UTHealthSup (MANUFACTURER UNKNOWN), cla130 (MANUFACTURER UNKNOWN) and allergy medications (unspecified) for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Jan2021 at 10:00 the patient experienced left palm turned yellow, like a highlighter was broke in it. After receiving vaccine, 45 minutes later when patient got back to work, noticed that palm had turned yellow. The patient reported that three months later too palm was still yellow. The patient reported it to be brighter some days than other days and that yellow seemed to be spread down fingers slowly. The patient reported that she received second shot in the right arm to see if its similar thing would happen again; but it did not. The patient reported that had no discomfort, pain or itching. No therapeutic measures were taken as a result of the reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event left palm turned yellow was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Peripheral swelling
Clinical narrative: Right arm pit is sore; Right arm pit swollen.; Possibly the lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 29Mar2021 at 17:00(at the age of 59-year-old), as a single dose for COVID-19 immunisation. Medical history included blood pressure high, iodine allergy and shellfish allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 08Mar2021 at 17:00 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 06:00, the patient experienced under right arm, in the armpit was sore and swollen. Possibly the lymph nodes. The patient did not receive any treatment for the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events right arm pit sore, swollen and swollen lymph nodes were not recovered at the time of reporting.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bradyphrenia, Burning sensation, Fatigue, Herpes zoster
Clinical narrative: Eignt days after, slept as muchas 13-14 hours (normally 7.5 hours).; shingles; tired; No stamina; Thinking is slower; joint stiffness in am; muscle aches; burning sensations in palms and lower legs; ribs ache; This is a spontaneous report received from a contactable healthcare professional, the patient. A 65-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route of administration in the left arm on 20Mar2021 at 14:45 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included shingles and lyme disease. The patient was known allergic to codeine (MANUFACTURER UNKNOWN), jellyfish and latex. The patient did not receive any medication within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021, within 48 hours, the patient experienced shingles, increasingly tired over the next 12 days. On 28Mar2021, eight days after the vaccination, the patient slept as much as 13-14 hours (normally 7.5 hours) (hypersomnia). It was reported that the patient had no stamina, cannot work for more than a couple hours and thinking was slower than usual and had some joint stiffness. The adverse events resulted in a doctors or other healthcare visit/professional office/clinic visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events shingles, increasingly tired,  the patient slept as much as 13-14 hours normally 7.5 hours , no stamina, thinking was slower, joint stiffness in arm, muscle aches, burning sensations in palms and lower legs and ribs ache was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Joint stiffness, Myalgia, Pain
Clinical narrative: Eignt days after, slept as muchas 13-14 hours (normally 7.5 hours).; shingles; tired; No stamina; Thinking is slower; joint stiffness in am; muscle aches; burning sensations in palms and lower legs; ribs ache; This is a spontaneous report received from a contactable healthcare professional, the patient. A 65-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route of administration in the left arm on 20Mar2021 at 14:45 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included shingles and lyme disease. The patient was known allergic to codeine (MANUFACTURER UNKNOWN), jellyfish and latex. The patient did not receive any medication within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021, within 48 hours, the patient experienced shingles, increasingly tired over the next 12 days. On 28Mar2021, eight days after the vaccination, the patient slept as much as 13-14 hours (normally 7.5 hours) (hypersomnia). It was reported that the patient had no stamina, cannot work for more than a couple hours and thinking was slower than usual and had some joint stiffness. The adverse events resulted in a doctors or other healthcare visit/professional office/clinic visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events shingles, increasingly tired,  the patient slept as much as 13-14 hours normally 7.5 hours , no stamina, thinking was slower, joint stiffness in arm, muscle aches, burning sensations in palms and lower legs and ribs ache was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Cluster headache, Hypertension
Clinical narrative: High Blood pressure; cluster headaches; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 25Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient previously took vaccine for shingles in the left arm on 02Feb2021 within four weeks prior to the COVID-19 vaccination. Medical history included thyroid, high cholesterol. The patient was allergic to sulfa drugs. Concomitant medications included levothyroxine sodium (SYNTHROID), rosuvastatin calcium (CRESTOR) and montelukast sodium (SINGULAIR) from an unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021, the patient experienced high blood pressure and cluster headaches for a week. Blood pressure normally on the low end, and it was running 150/100 (unspecified units). It was unknown if the patient received treatment for the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event high blood pressure and cluster headaches were unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: also had a headache that increasingly got worse until EMS arrived; Patient had pain radiating down from injection site; This is a spontaneous report from a contactable healthcare professional reporting for a patient. A 19-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 31Mar2021 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications. The patient did not have allergy to medications, food, or other products. It was reported as unknown about the pregnancy information. Prior to the vaccination, the patient diagnosed with COVID-19 was unknown. It was reported as unknown that the patient received any other vaccines within four weeks prior to the vaccination. Since the vaccination, it was unknown that the patient had been tested for COVID-19. On 31Mar2021 at 17:15 the patient experienced pain radiating down from injection site, headache worsened till EMS arrived. The event resulted in emergency room/department or urgent care. The treatment taken for the adverse events was unknown. The clinical outcome of the events pain radiating down from injection site and headache were unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Urticaria
Clinical narrative: Hives all over body; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8737) via an unspecified route of administration in the left arm on 29Mar2021 at 10:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to medications and food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er16199) via an unspecified route of administration in the left arm on 08Mar2021 at 17:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had tested for COVID-19. The patient underwent lab test post vaccination, which included nasal swab test on an unknown date in 2021 and the result was unknown. On 30Mar2021 at 16:00, the patient experienced hives all over the body. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient had taken self-dosing of BENADRYL as treatment for event hives all over body. The clinical outcome of the event hives all over body was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Vaccination site erythema
Clinical narrative: Horrible arm pain ( On a scale of 1-10it was an 11); Redness at injection site; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 31Mar2021 at 08:15 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no allergies to medications, food, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 22:45, the patient experienced horrible arm pain (On a scale of 1-10, it was an 11), redness at injection site and low grade fever (all these reaction had started after 14 hours of injection). The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event painful arm, injection site redness and low grade fever was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate decreased, Vaccination site vesicles
Clinical narrative: A large blister formed at the injection site; Resting heart rate has decreased suddenly from about 70 bpm to 66 bpm.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 14:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have a history of allergies to medications, food, or other products. The patient did not receive any other medications within two weeks of COVID-19 vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021, the patient experienced a large blister formed at the injection site hours after the injection and was persisting 4 days afterwards, and her resting heart rate was also decreased suddenly from about 70 bpm to 66 bpm. The patient contacted her doctor (left a message), and was waiting to hear back about what to do. No therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events large blister formed at the injection site and heart rate decreased was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: large raised bump on injection site; injection site itchy; injection site red.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8730), via an unspecified route of administration in the left arm on 23Mar2021 at 09:00 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included venlafaxine (MANUFACTURER UNKNOWN) and valsartan (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 30Mar2021 (also reported as 8 days after vaccination), the patient experienced large raised bump on injection site, itching and redness. The adverse events did not result in a visit to the doctors or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events large raised bump on injection site, itchy and redness were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Vaccination site pain
Clinical narrative: Pain at the site of the shot; chills; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 30Mar2021 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 11:30, the patient had pain at the site of the shot, chills and headache. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events pain at the site of the shot, chills and headache which included treatment with paracetamol (TYLENOL). The clinical outcomes of the events pain at the site of the shot, chills and headache were resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Paraesthesia
Clinical narrative: Tingly all over body.; Muscle aches; Arm soreness; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 31Mar2021 at 14:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included muscular dystrophy. The patient had allergies to mangoes. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and cetirizine (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 12Mar2021 at 14:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had not received any other vaccine within 4 weeks prior to the COVID vaccine. On 31Mar2021 at 14:00, the patient experienced tingly all over the body, muscle aches and arm soreness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measure was taken as a result of adverse events. The clinical outcome of the events was not recovered at the time of this report.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed, SARS-CoV-2 test
Clinical narrative: Period is very late; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 26Mar2021 at 11:30 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) taken for unknown indication and unknown start date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021, the patient was supposed to start period the day after the vaccine but the patient did not have. The patient menstrual cycle was usually very regular but period was very late and was not pregnant. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the menstruation delayed. The clinical outcome of the event menstruation delayed was unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Rash
Clinical narrative: rash and swelling around right eye; swelling around right eye; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: UNKNOWN) via an unspecified route of administration on 23Mar2021 at 16:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021, the patient experienced rash and swelling around right eye. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events rash and swelling around right eye was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder discomfort, Bladder pain, Discomfort, Renal pain
Clinical narrative: experiencing moderate pain and discomfort in kidneys and bladder.; experiencing moderate pain and discomfort in kidneys and bladder.; experiencing moderate pain and discomfort in kidneys and bladder; experiencing moderate pain and discomfort in kidneys and bladder; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 13:15 hours (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have relevant medical history. The patient was allergic to opiates. The patient did not receive concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 19:30 hours the patient experienced experienced moderate pain and discomfort in kidneys and bladder within 6 hours of vaccination. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event moderate pain and discomfort in kidneys and bladder was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Somnolence
Clinical narrative: extremely tired; sore; sleepy; This is a spontaneous report from a contactable healthcare professional, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732), via an unspecified route of administration on the left arm on 26Mar2021 at 17:30(at the age of 43-year-old), as a single dose for COVID-19 immunisation. Medical history included hypertension and endometriosis. Concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 07:30, the patient experienced extremely tired, sore and sleepy since receiving injection. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extremely tired, sore and sleepy was not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature abnormal, Chills, Headache
Clinical narrative: Severe weakness; Chills; Fever (~100f); Joint pain; Headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 28Mar2021 at 18:00(at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included amblyopia, blood pressure high and strabismus. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 03:30, the patient experienced chills, fever (~100f), joint pain, headache, severe weakness. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with over-the-counter ibuprofen. The clinical outcomes of the event chills, fever (~100f), joint pain, headache, sever weakness were recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Severe weakness; Chills; Fever (~100f); Joint pain; Headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 28Mar2021 at 18:00(at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included amblyopia, blood pressure high and strabismus. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 03:30, the patient experienced chills, fever (~100f), joint pain, headache, severe weakness. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with over-the-counter ibuprofen. The clinical outcomes of the event chills, fever (~100f), joint pain, headache, sever weakness were recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain
Clinical narrative: Body temperature; chills; body aches; This is a spontaneous report received from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er2013) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 12:00 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. The patient's medical history was reported as COVID-19 prior to vaccination. The patient did not have a history of allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in an unspecified anatomical site on an unspecified date (at the age of 52-years-old), as a single dose for COVID-19 immunisation.  The patient had not received other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not received any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021 at 22:00, the patient experienced 99.9 temperature with chills and body aches, similar to when she had Covid-19 in Dec2020. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. On an unspecified date, the patient underwent body temperature recording and the result was temperature 99.9(unspecified units). The clinical outcomes for the events 99.9 temperature with chills and body aches was recovered in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Head discomfort, Myalgia
Clinical narrative: Fatigue; Fever; Mild joint achiness; Neck muscles sore; Pressure in head; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 24Mar2021 at 16:15 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had food, grass and sesame seeds allergy. Concomitant medications included hydrochlorothiazide, valsartan (VALSARTAN HCTZ), amlodipine (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the arm left on 03Mar2021 at 16:45 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 08:00 the patient experienced fatigue, fever, mild joint achiness, neck muscles sore and pressure in head. No therapeutic measures were taken as a result of the events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event fatigue, fever, mild joint achiness, neck muscles sore and pressure in head was recovered on an unspecified date.    No follow-up attempts are needed. No further information is expected.